New way of genome editing could cure hemophilia in mice; may be safer than older method, study shows
A technique developed by Stanford researchers could provide a safer, longer-lasting method of replacing faulty, disease-causing genes with working copies.
New molecular imaging technology could improve bladder-cancer detection, researchers say
Researchers have developed a new imaging method that targets a protein known as CD47 in human bladder cancer. This technology may greatly improve cancer detection and enable more accurate surgeries.
Study finds brain abnormalities in chronic fatigue patients
Radiology researchers have discovered that the brains of patients with chronic fatigue syndrome have diminished white matter and white matter abnormalities in the right hemisphere.
Group classes teach parents effective autism therapy, study finds
Parents who learned an autism therapy in group classes helped their children with the disorder improve their language skills, a new study has found.
‘Every life is touched by suicide’: Stanford psychiatrist discusses importance of suicide prevention
Stanford aims to model best practices in training psychiatrists to prevent, and cope with, suicides.
Competition keeps health-care costs low, researchers find
Physician practices in areas with low competition charge more for office visits than practices in areas with high competition.
For inmates, pricey hepatitis C drug could make financial sense
Despite its $7,000-per-week cost, sofosbuvir provides better value than other current treatments for prisoners with hepatitis C, according to Stanford researchers.
Antibiotics may help Salmonella spread in infected animals, scientists learn
Salmonella-infected mice that were given antibiotics became sicker and began shedding far more bacteria in their feces than they had before.
Fall issue of Stanford Medicine reports on the immune system's balancing act
The new issue includes “Balancing act: The immune system,” a series of articles on how the immune system protects us and what happens when it becomes overzealous.
Cardiology researcher and mentor Edwin Alderman dies at 76
Over four decades at Stanford, Edwin Alderman trained hundreds of future cardiologists and led groundbreaking clinical trials. But he always made patients a priority.
Leading the Biomedical Revolution
We are in the middle of a biomedical revolution more profound and far-reaching than the industrial and digital revolutions that made it possible.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.